Kurt J. Andrews - Net Worth and Insider Trading
Kurt J. Andrews Net Worth
The estimated net worth of Kurt J. Andrews is at least $400,800 dollars as of 2024-09-14. Kurt J. Andrews is the SVP, Human Resources of Amicus Therapeutics Inc and owns about 35,469 shares of Amicus Therapeutics Inc (FOLD) stock worth over $400,800. Details can be seen in Kurt J. Andrews's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kurt J. Andrews has not made any transactions after 2018-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kurt J. Andrews
Kurt J. Andrews Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kurt J. Andrews owns 2 companies in total, including Immunomedics Inc (IMMU) , and Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of Kurt J. Andrews’s form 4 insider trades.
Insider Ownership Summary of Kurt J. Andrews
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMMU | Immunomedics Inc | 2020-03-04 | Chief Human Resources Officer |
| FOLD | Amicus Therapeutics Inc | 2018-07-02 | SVP & Human Resources |
Kurt J. Andrews Latest Holdings Summary
Kurt J. Andrews currently owns a total of 1 stock. Kurt J. Andrews owns 35,469 shares of Amicus Therapeutics Inc (FOLD) as of July 2, 2018, with a value of $400,800.
Latest Holdings of Kurt J. Andrews
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2018-07-02 | 35,469 | 11.30 | 400,800 |
Holding Weightings of Kurt J. Andrews
Kurt J. Andrews Form 4 Trading Tracker
According to the SEC Form 4 filings, Kurt J. Andrews has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 5,000 shares on July 2, 2018, which brought Kurt J. Andrews around $78,150.
Insider Trading History of Kurt J. Andrews
- 1
Kurt J. Andrews Trading Performance
Kurt J. Andrews Ownership Network
Kurt J. Andrews Owned Company Details
What does Immunomedics Inc do?
Who are the key executives at Immunomedics Inc?
Kurt J. Andrews is the Chief Human Resources Officer of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .
Immunomedics Inc (IMMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunomedics Inc Insider Transactions
Kurt J. Andrews Mailing Address
Above is the net worth, insider trading, and ownership report for Kurt J. Andrews. You might contact Kurt J. Andrews via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
